Literature DB >> 7373344

Remyelination by cells introduced into a stable demyelinating lesion in the central nervous system.

B M Harrison.   

Abstract

Schwann cells from an autogeneic peripheral nerve source were injected into an established demyelinating lesion produced by the direct micro-injection of diphtheria toxin into the cat spinal cord. In control diphtheria toxin lesions, which were not injected with Schwann cells, demyelination and some oligodendrocyte remyelination was seen but Schwann cell remyelination was not observed. In diphtheria toxin lesions which were wholly confined to the posterior columns, Schwann cell myelin was not seen before 3 weeks after cell injection. The Schwann cell myelinated fibres occurred singly or in small groups within the posterior columns and were considered to have been myelinated by injected Schwann cells. By one month Schwann cell myelinated fibres had thick myelin sheaths but many demyelinated axons remained. By contrast, in more extensive diphtheria toxin lesions there was widespread Schwann cell remyelination of central axons at all stages examined after cell injection. The Schwann cell myelinated fibres were grouped in large numbers around the damaged dorsal root entry zones, the likely source of Schwann cells in these lesions. It is concluded that CNS remyelination may be improved by the injection of peripheral Schwann cells although the extent of remyelination is limited. One facet limiting remyelination may be the concentration of Schwann cells that it is possible to inject with present techniques. Functional recovery remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7373344     DOI: 10.1016/0022-510x(80)90044-1

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Cell therapy in demyelinating diseases.

Authors:  Claire Rice; Christopher Halfpenny; Neil Scolding
Journal:  NeuroRx       Date:  2004-10

Review 2.  Strategies for achieving and monitoring myelin repair.

Authors:  Claire Rice; Neil Scolding
Journal:  J Neurol       Date:  2007-03-07       Impact factor: 4.849

3.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 4.  Schwann cell invasion of the central nervous system of the myelin mutants.

Authors:  I D Duncan; R L Hoffman
Journal:  J Anat       Date:  1997-01       Impact factor: 2.610

5.  The interaction of Schwann cells with CNS axons in regions containing normal astrocytes.

Authors:  W F Blakemore; A J Crang; R Curtis
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

6.  The demonstration of recurrent demyelination and remyelination of axons in the central nervous system.

Authors:  E S Johnson; S K Ludwin
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

Review 7.  Therapeutic strategies in multiple sclerosis. II. Long-term repair.

Authors:  N Scolding
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1999-10-29       Impact factor: 6.237

Review 8.  Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury.

Authors:  Jeffery D Kocsis; Karen L Lankford; Masanori Sasaki; Christine Radtke
Journal:  Neurosci Lett       Date:  2009-01-17       Impact factor: 3.046

9.  Contribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.

Authors:  Kristel Kegler; Ingo Spitzbarth; Ilka Imbschweiler; Konstantin Wewetzer; Wolfgang Baumgärtner; Frauke Seehusen
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

Review 10.  Requirements for Schwann cell migration within CNS environments: a viewpoint.

Authors:  R J Franklin; W F Blakemore
Journal:  Int J Dev Neurosci       Date:  1993-10       Impact factor: 2.457

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.